MedPath

An Interventional study with LM Potency on patients with grade 1 Hypertensio

Phase 2
Conditions
Health Condition 1: I10- Essential (primary) hypertension
Registration Number
CTRI/2024/04/066570
Lead Sponsor
DrArfana Chauhan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Participants must have a confirmed diagnosis of essential hypertension as per established medical criteria

Participants with baseline Systolic Blood Pressure

more than 120 to 159 and Diastolic Blood Pressure more than 80 to 99 who are not on any anti hypertensive medicines

Participants with a body mass index of 25 to 35

Participants willing to provide informed consent to participate in the study and also who can fill up the Questionnaire

Exclusion Criteria

Patients who are suffering from secondary Hypertension of known aetiology such as renal disease pheochromocytoma or Cushing’s syndrome known diabetics, history of myocardial infarction severe coronary artery disease or clinically significant heart failure or valvular defect or known cases of cardiac diseases any systemic illness consumptive disease autoimmune disease cancer hepatic disease renal disease

Patients receiving any drugs known to affect Blood Pressure or medical treatments that can influence the Blood Pressure having a history of alcohol or drug abuse

Women who are taking contraceptive pills pregnancy and lactating mother

Patients having class 2 and class 3 obesity

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath